Human papillomavirus association with head and neck cancers: Understanding virus biology and using it in the development of cancer diagnostics

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 1, 2008, Pages 11-20

  Strati, Katerina ^a   Lambert, Paul F ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Department of Oncology ^*  (United States)

Author keywords

Biomarkers; E6; E7; Head and neck cancer; HPV; Human papillomavirus

Indexed keywords

PROTEIN E6; PROTEIN E7;

CANCER DIAGNOSIS; GENETIC ASSOCIATION; HEAD AND NECK CARCINOMA; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; WART VIRUS;

EID: 77953460750     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.1.11     Document Type: Review

References (90)

1. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2(5):342-350 (Pubitemid 37328947)
2. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995;69(5):2989-2997
3. Schwarz E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314(6006):111-114 (Pubitemid 15142033)
4. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985;119(3):361-366 (Pubitemid 15051884)
5. Munoz N, Bosch FX, De Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348(6):518-527 (Pubitemid 36159887)
6. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12-19 (Pubitemid 29406813)
7. D'souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356(19):1944-56 •• This case-control study demonstrates that high-risk sexual behaviour, exposure to HPV and HPV infection increase the risk for HNSCC.
8. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004;31(6):744-754 (Pubitemid 39602680)
9. Gillison ML. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol 2006;24(36):5623-5625 (Pubitemid 46631299)
10. Dahlstrom KR, Adler-Storthz K, Etzel CJ, et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 2003;9(7):2620-2626 (Pubitemid 36842105)
11. Hansson BG, Rosenquist K, Antonsson A, et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125(12):1337-1344 (Pubitemid 41722001)
12. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95(23):1772-1783 (Pubitemid 38008900)
13. Rosenquist K, Wennerberg J, Schildt EB, et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125(12):1327-1336
14. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90(21):1626-1636 (Pubitemid 28523437)
15. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004;96(6):449-455 (Pubitemid 38443648)
16. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004;108(5):766-772 (Pubitemid 38076410)
17. Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000;11(6):489-495 (Pubitemid 30342838)
18. Hammarstedt L, Dahlstrand H, Lindquist D, et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 2007;127(9):988-992 (Pubitemid 47345807)
19. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004;57(5):449-455 (Pubitemid 38621787)
20. Snijders PJ, Meijer CJ, Van Den Brule AJ, et al. Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol 1992;73(Pt 8):2059-2066
21. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119(11):2620-2623 (Pubitemid 44691317)
22. Mellin H, Dahlgren L, Munck-Wikland E, et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002;102(2):152-8 • Demonstrates that HPV positivity in HNSCC is a positive prognostic factor. (Pubitemid 35168028)
23. Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004;112(6):1015-9 • Demonstrates that HPV positivity in HNSCC is a positive prognostic factor.
24. Farhadi M, Tahmasebi Z, Merat S, et al. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 2005;11(8):1200-1203 (Pubitemid 40353009)
25. Yao PF, Li GC, Li J, et al. Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma. World J Gastroenterol 2006;12(9):1352-1355
26. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92(9):709-720 (Pubitemid 30365531)
27. Niedobitek G, Pitteroff S, Herbst H, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 1990;43(11):918-921 (Pubitemid 20359873)
28. Snijders PJ, Cromme FV, Van Den Brule AJ, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992;51(6):845-850
29. Balz V, Scheckenbach K, Gotte K, et al. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 2003;63(6):1188-1191 (Pubitemid 36348693)
30. Ragin CC, Taioli E, Weissfeld JL, et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 2006;95(10):1432-1438 (Pubitemid 44760098)
31. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24(5):736-747 (Pubitemid 46622040)
32. Hafkamp HC, Speel EJ, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003;107(3):394-400 (Pubitemid 37266459)
33. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002;21(10):1510-1517 (Pubitemid 34226138)
34. Dong SM, Sun DI, Benoit NE, et al. Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 2003;9(10 Pt 1):3635-3640 (Pubitemid 37169228)
35. Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998;152(1):145-156 (Pubitemid 28028055)
36. Pyeon D, Newton MA, Lambert PF, et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 2007;67(10):4605-19 •• Demonstrates distinct transcriptional patterns associated with HPV-positive HNSCC. (Pubitemid 46910165)
37. Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res (2006)12(3 Pt 1):701-9 •• Demonstrates distinct transcriptional patterns associated with HPV-positive HNSCC.
38. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000;89(3):300-304 (Pubitemid 30430748)
39. Kutler DI, Wreesmann VB, Goberdhan A, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 2003;95(22):1718-1721 (Pubitemid 37509080)
40. Lowy DR, Gillison ML. A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst 2003;95(22):1648-1650 (Pubitemid 37509065)
41. Roberts JN, Buck CB, Thompson CD, et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 2007;13(7):857-861 (Pubitemid 47038188)
42. Laimins CLAL. The life cycle of human papillomaviruses in keratinocytes. In: The Papillomaviruses . DiMaio RLGaD, editor, Springer Science, New York; 2007. p. 45-67
43. Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991;10(13):4129-4135 (Pubitemid 21905444)
44. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75(3):495-505 (Pubitemid 23335075)
45. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248(4951):76-79 (Pubitemid 20139274)
46. Munger K, Basile JR, Duensing S, et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001;20(54):7888-7898 (Pubitemid 33135315)
47. Schiller JT, Vass WC, Vousden KH, Lowy DR. E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J Virol 1986;57(1):1-6 (Pubitemid 16147910)
48. Goodwin EC, Dimaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 2000;97(23):12513-12518 (Pubitemid 30840447)
49. Goodwin EC, Yang E, Lee CJ, et al. Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci USA 2000;97(20):10978-10983 (Pubitemid 30751264)
50. Crook T, Storey A, Almond N, Osborn K, Crawford L. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci USA 1988;85(23):8820-8824 (Pubitemid 19001797)
51. Matlashewski G, Schneider J, Banks L, et al. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J 1987;6(6):1741-1746
52. Phelps WC, Yee CL, Munger K, Howley PM. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 1988;53(4):539-547
53. Li SL, Kim MS, Cherrick HM, Doniger J, Park NH. Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens. Carcinogenesis 1992;13(11):1981-1987
54. Liu X, Han S, Baluda MA, Park NH. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene 1997;14(19):2347-2353 (Pubitemid 27260727)
55. Park NH, Gujuluva CN, Baek JH, et al. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 1995;10(11):2145-2153
56. Al Moustafa AE, Foulkes WD, Benlimame N, et al. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene 2004;23(2):350-358 (Pubitemid 38174988)
57. Herber R, Liem A, Pitot H, Lambert PF. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol 1996;70(3):1873-1881 (Pubitemid 26062951)
58. Song S, Pitot HC, Lambert PF. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 1999;73(7):5887-5893 (Pubitemid 29274875)
59. Riley RR, Duensing S, Brake T, et al. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 2003;63(16):4862-4871 (Pubitemid 37022618)
60. Song S, Liem A, Miller JA, Lambert PF. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 2000;267(2):141-150 (Pubitemid 30123597)
61. Strati K, Pitot HC, Lambert PF. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci USA 2006;103(38):14152-14157 (Pubitemid 44452995)
62. Kranendonk M, Pintado F, Mesquita P, et al. MX100, a new Escherichia coli tester strain for use in genotoxicity studies. Mutagenesis 1996;11(4):327-333 (Pubitemid 26235483)
63. Panigrahi GB, Walker IG. The N2-guanine adduct but not the C8-guanine or N6-adenine adducts formed by 4-nitroquinoline 1-oxide blocks the 3′-5′ exonuclease action of T4 DNA polymerase. Biochemistry 1990;29(8):2122-2126 (Pubitemid 20085440)
64. Ramotar D, Belanger E, Brodeur I, Masson JY, Drobetsky EA. A yeast homologue of the human phosphotyrosyl phosphatase activator PTPA is implicated in protection against oxidative DNA damage induced by the model carcinogen 4-nitroquinoline 1-oxide. J Biol Chem 1998;273(34):21489-21496 (Pubitemid 28405316)
65. Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res. 2004;10(1 Pt 1):301-313 (Pubitemid 38114193)
66. Venkat JA, Shami S, Davis K, et al. Relative genotoxic activities of pesticides evaluated by a modified SOS microplate assay. Environ Mol Mutagen 1995;25(1):67-76
67. Haupt Y, Maya R, Kazaz A, OREN M. Mdm2 promotes the rapid degradation of p53. Nature 1997;387(6630):296-299 (Pubitemid 27220766)
68. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997;387(6630):299-303 (Pubitemid 27220767)
69. Mietz JA, Unger T, Huibregtse JM, Howley PM. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J 1992;11(13):5013-5020 (Pubitemid 23023445)
70. Shai A, Brake T, Somoza C, Lambert PF. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 2007;67(4):1626-1635 (Pubitemid 46383388)
71. Simonson SJ, Difilippantonio MJ, Lambert PF. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res 2005;65(18):8266-8273 (Pubitemid 41330591)
72. Collins AS, Nakahara T, Do A, Lambert PF. Interactions with pocket proteins contribute to the role of human papillomavirus type 16 E7 in the papillomavirus life cycle. J Virol 2005;79(23):14769-14780 (Pubitemid 41636275)
73. Heck DV, Yee CL, Howley PM, Munger K. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci USA 1992;89(10):4442-4446
74. Munger K, Yee CL, Phelps WC, et al. Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences. J Virol 1991;65(7):3943-3948
75. Strati K, Lambert PF. Role of Rb-dependent and independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res 2008;67(24):11585-11593
76. Maufort JP, Williams SM, Pitot HC, Lambert PF. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res 2007;67(13):6106-6112 (Pubitemid 47037490)
77. Chang JL, Tsao YP, Liu DW, et al. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci 2001;8(2):206-213 (Pubitemid 32268558)
78. Leechanachai P, Banks L, Moreau F, Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992;7(1):19-25
79. Pim D, Collins M, Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992;7(1):27-32
80. Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 2006;24(17):2666-2672 (Pubitemid 46622088)
81. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354(6):567-578 (Pubitemid 43209104)
82. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006;24(36):5630-6 • Demonstrates that HPV positivity in HNSCC is a positive prognostic factor. (Pubitemid 46631302)
83. Soderlund-Strand A, Rymark P, Andersson P, Dillner J, Dillner L. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J Clin Microbiol 2005;43(7):3260-3266 (Pubitemid 40981333)
84. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121(11):2465-72 •• Demonstrates that biomarker staining in addition to HPV DNA testing in tumor samples increases specificity over individual screening methods.
85. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153(6):1741-1748 (Pubitemid 28550662)
86. Brake T, Connor JP, Petereit DG, Lambert PF. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 2003;63(23):8173-8180 (Pubitemid 37549465)
87. Mukherjee G, Muralidhar B, Bafna UD, Laskey RA, Coleman N. MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India. Br J Cancer 2007;96(7):1107-1111 (Pubitemid 46608320)
88. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25(7):884-891 (Pubitemid 32594981)
89. Quade BJ, Park JJ, Crum CP, Sun D, Dutta A. In vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998;11(12):1238-1246
90. Williams GH, Romanowski P, Morris L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 1998;95(25):14932-14937 (Pubitemid 29003734)